Rivfloza

Drug Novo Nordisk AS
Total Payments
$1.1M
Transactions
984
Doctors
634
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2024 $1.1M 984 634

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $993,684 92 92.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $40,836 10 3.8%
Food and Beverage $23,044 847 2.1%
Consulting Fee $10,138 14 0.9%
Travel and Lodging $9,454 20 0.9%
Space rental or facility fees (teaching hospital only) $3,500 1 0.3%

Payments by Type

Research
$993,684
92 transactions
General
$86,971
892 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
DCR-PHXC-301 Novo Nordisk AS $637,689 0
DCR-PHXC-204 Novo Nordisk AS $168,613 0
DCR-PHXC-502 Novo Nordisk AS $104,877 0
DCR-PHXC-203 Novo Nordisk AS $82,506 0

Top Doctors Receiving Payments for Rivfloza — Page 6

Doctor Specialty Location Total Records
, M.D Urology Houston, TX $45.84 2
, MD Nephrology San Antonio, TX $45.71 2
, APRN-CNP Nurse Practitioner San Antonio, TX $45.70 2
, M.D Internal Medicine San Antonio, TX $45.70 2
, M.D Nephrology San Antonio, TX $45.70 2
, MD Nephrology San Antonio, TX $45.70 2
, M.D Nephrology Shawnee, KS $45.60 2
, MD Nephrology Albuquerque, NM $45.59 2
, M.D Internal Medicine New Orleans, LA $45.56 2
, M.D Internal Medicine New Orleans, LA $45.56 2
, ACNP Acute Care New Orleans, LA $45.56 2
, M.D Urology Baltimore, MD $45.50 2
, M.D Student in an Organized Health Care Education/Training Program Houston, TX $45.50 2
, M.D Urology Baltimore, MD $45.50 2
, PA-C Physician Assistant San Antonio, TX $44.80 2
, MD Urology Oklahoma City, OK $44.51 2
, APRN, FNP-C Family Colorado Springs, CO $44.37 2
, MD Nephrology Aurora, CO $44.36 2
, FNP-C Nurse Practitioner Austin, TX $44.25 2
, M.D Vascular & Interventional Radiology Austin, TX $44.21 2
, MD Urology Round Rock, TX $44.21 2
, MD Urology Tulsa, OK $44.16 2
, CNP Adult Health Albuquerque, NM $43.93 2
, M.D Internal Medicine Albuquerque, NM $43.93 2
, M.D Nephrology Albuquerque, NM $43.93 2

About Rivfloza

Rivfloza is a drug associated with $1.1M in payments to 634 healthcare providers, recorded across 984 transactions in the CMS Open Payments database. The primary manufacturer is Novo Nordisk AS.

Payment data is available from 2024 to 2024. In 2024, $1.1M was paid across 984 transactions to 634 doctors.

The most common payment nature for Rivfloza is "Unspecified" ($993,684, 92.0% of total).

Rivfloza is associated with 4 research studies, including "DCR-PHXC-301" ($637,689).